Skip to main content
OpenTrials
Completed

NCT Number: NCT00759616

Outcome Analysis of the Oxford Partial Knee Arthroplasty

Prospectively monitor the patients receiving the Oxford Partial knee arthroplasty

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Knee Arthroplasty

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Dartmouth General Hospital

Dartmouth, Canada

About this study

Utilization of systematic outcome measurements and specific designated time frames to monitor patient satisfactions will assist in analysing this type of prosthesis and the post operative period. Data collected will be added to the compiled information from previous studies in relation to the Oxford knee.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient Suitable for Knee Replacement

Exclusion criteria

Treatment and study plan

Oxford Partial Knee

Device

Oxford Partial Knee

Primary outcomes

  1. WOMAC, SF12, oxford Knee,KSCRS

    Time frame: 3weeks, 3months,6months, yearly

Secondary outcomes

  1. Length of Hospital Stay

    Time frame: Postop

Sponsors and collaborators

Lead sponsor

Zimmer Biomet

Industry

Collaborators

  • Dartmouth General Hospital

Registry information

Important dates

Study start
2003
Primary completion
2009
Study completion
2009
First posted
Sep 25, 2008
Registry last updated
Jun 16, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.